series-a
Stage
1
Investors
About
Dragonfly Therapeutics is a clinical-stage biotechnology company developing targeted immunotherapies by harnessing the immune system to improve patient outcomes in oncology and immunology.
Explore Dragonfly Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.